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Presynaptic inhibition onto axons regulates neuronal
output, but how such inhibitory synapses develop
and are maintained in vivo remains unclear. Axon
terminals of glutamatergic retinal rod bipolar cells
(RBCs) receive GABAA and GABAC receptor-medi-
ated synaptic inhibition. We found that perturbing
GABAergic or glutamatergic neurotransmission
does not prevent GABAergic synaptogenesis onto
RBC axons. But, GABA release is necessary for
maintaining axonal GABA receptors. This activity-
dependent process is receptor subtype specific:
GABAC receptors are maintained, whereas GABAA
receptors containing a1, but not a3, subunits
decrease over time in mice with deficient GABA syn-
thesis. GABAA receptor distribution on RBC axons is
unaffected in GABAC receptor knockout mice. Thus,
GABAA and GABAC receptor maintenance are regu-
lated separately. Although immature RBCs elevate
their glutamate release when GABA synthesis is
impaired, homeostatic mechanisms ensure that the
RBC output operates within its normal range after
eye opening, perhaps to regain proper visual pro-
cessing within the scotopic pathway.
INTRODUCTION
Presynaptic inhibition onto axonal terminals, commonly pro-
vided by GABAergic transmission, regulates neurotransmitter
release. GABA receptors on the axon hillock of pyramidal cells
(Nusser et al., 1996; Szabadics et al., 2006), on mossy fiber
terminals of hippocampal granule cells (Ruiz et al., 2003), on
cerebellar parallel fibers (Stell et al., 2007), and on retinal bipolar
cell axon terminals (Shields et al., 2000; Vardi and Sterling, 1994)
serve to modulate action potential firing and neurotransmitter
release (Kullmann et al., 2005; Luscher et al., 2011). Although
much is known about how presynaptic GABAergic inhibition124 Neuron 78, 124–137, April 10, 2013 ª2013 Elsevier Inc.shapes neuronal output, mechanisms that regulate the develop-
ment and maintenance of such inhibition onto axon terminals
are not yet well understood. Here, we addressed the role of
neurotransmission in the development, maturation, and mainte-
nance of GABAergic synapses onto axonal terminals involved
in modulation of neurotransmitter release. To do so, we took
advantage of a well-characterized circuit in the mammalian
retina, where glutamate release from axons is regulated by
robust presynaptic GABAergic inhibition.
At dim light levels, visual information from rod photoreceptors
is conveyed to rod bipolar cells (RBCs), which relay the signal to
amacrine cells in the inner retina (reviewed by Wa¨ssle, 2004).
Specifically, RBCs contact GABAergic A17 amacrine cells
(A17s) (Nelson and Kolb, 1985), which provide local feedback
inhibition onto the rod bipolar cell axon terminals to modulate
their release of glutamate (Cha´vez et al., 2006; Chun et al.,
1993; Hartveit, 1999). In addition, RBC axon terminals also
receive GABAergic drive from other widefield amacrine cells
(Cha´vez et al., 2010; McGuire et al., 1984). Unlike other parts
of the brain in which GABAergic inhibition is mediated mainly
by GABAA receptors, GABAergic input onto RBC axon terminals
involves both GABAA and GABAC receptor types (Enz et al.,
1996; Koulen et al., 1998). GABAA and GABAC receptors do
not cocluster at the same synaptic site but are expressed at
different postsynaptic sites on RBC axon terminals (Fletcher
et al., 1998; Koulen et al., 1998). There are also functional differ-
ences between the two receptor types: GABAA receptors are
less sensitive to GABA but have faster kinetics compared to
GABAC receptors, and thus the two receptor types regulate
different aspects of glutamate release from RBCs (Eggers and
Lukasiewicz, 2006b; Sagdullaev et al., 2006). The diversity of
GABA receptors on RBCs presents an ideal opportunity to inves-
tigate how neurotransmission regulates the development and
maintenance of not only GABA receptors but also different
GABA receptor types on the same axon terminal.
To examine the role of neurotransmission on the formation and
maintenance of axonal GABA receptors, we utilized transgenic
mice in which GABAergic or glutamatergic transmission is per-
turbed throughout the period of circuit assembly. Using electron
microscopy, immunohistochemistry, and electrophysiology, we
assessed whether perturbed neurotransmission affects the
Figure 1. Development of GABAergic Syn-
apses onto RBC Axon Terminals
(A) Schematic showing RBC connections with
amacrine cells in retina IPL. RBCs (blue) provide
excitatory glutamatergic drive onto glycinergic AII
(gray) and GABAergic A17 (orange) amacrine cells.
In turn, they receive feedback inhibition from A17
cells and additional GABAergic input from other
as-yet-unidentified amacrine cells (AC; red).
(B) PKC-labeled RBC terminals (red) colabeled
with GAD67 or GAD65 (cyan) reveal more abun-
dant immunoreactivity of GAD67 as compared to
GAD65 in the IPL lamina, where RBC axons
stratify.
(C) Quantification of percent volume of GAD signal
overlapping with PKC immunoreactivity revealed a
significantly higher percent overlap with GAD67-
positive processes as compared to GAD65.
Asterisk marks significant difference.
(D) Development of contacts (arrows) between
RBCs (red) and GAD67-GFP-positive amacrine
processes (cyan) in the grm6-tdtomato3 GAD67-
GFP double transgenic line. By P15, large vari-
cosities can be seen at sites of contact between
RBC axon terminals and GAD67-GFP amacrine
processes.
(E) Axonal terminals of P12 PKC-labeled RBCs
(blue) express GABAAa1, GABAAa3, and GABACr
receptor clusters (yellow), indicating the presence
of these three GABAergic postsynapses on RBC
terminals before eye opening.
(F) P30 RBCs in the grm6-tdtomato transgenic line
(left, vertical view, grayscale). Axonal terminals of
individual P30 RBCs (horizontal view, blue) ex-
press all three GABA receptor cluster types:
GABAAa1, GABAAa3, and GABACr (yellow).
See also Figures S1 and S2.
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Presynaptic Inhibition on Axonal Terminalsstructural formation and maintenance of GABA receptor sub-
types on RBC axon terminals. Because RBC terminals also
receive some glycinergic inhibition (Eggers et al., 2007, Wa¨ssle
et al., 2009), we further analyzed whether an upregulation of
glycine receptors occurred to compensate for the reduction in
GABAergic transmission. Furthermore, we asked whether the
loss of GABAergic inhibition causes alterations to RBC output
beyond that expected solely from disinhibition in the GABA-defi-
cient circuit. Because GABA release from A17 amacrine cells
normally requires RBC drive due to the reciprocal synaptic
arrangement between these two cell types, we determinedNeuron 78, 124–1whether lack of GABAergic transmission
also caused developmental changes in




Synapses on RBC Axon Terminals
GABAergic inhibition onto axon terminals
of RBCs is mediated by a variety of ama-crine cells, including A17 cells that provide reciprocal feedback
inhibition (Figure 1A). GABA is synthesized in amacrine cells by
two isoforms of glutamate decarboxylase, GAD67 and GAD65
(Haverkamp and Wa¨ssle, 2000; Vardi and Auerbach, 1995). We
found that in the sublamina of the inner plexiform layer (IPL)
where RBC axonal terminals stratify (sublamina 5, ON-layer),
GAD67 immunoreactivity was more abundant compared to
GAD65 (Figure 1B). Quantification of the immunolabeling (see
Experimental Procedures) showed that dendritic processes
positive for GAD67 exhibited greater volume overlap with protein
kinase C (PKC) immunoreactive RBC axonal boutons, compared37, April 10, 2013 ª2013 Elsevier Inc. 125
Figure 2. Inhibitory Synapses onto RBC Axons in grm6-TeNT and
GAD1KO Retina
(A) Schematic showing RBC axon terminal circuitry in wild-type and transgenic
lines with suppressed glutamatergic (glu) transmission from ON-bipolar cells
(grm6-TeNT) and reduced GABAergic transmission from amacrine cells
(GAD1KO).
(B) Immunolabeling for VIAAT (yellow) at the level of PKC-positive RBC
boutons (blue) in P30 wild-type, grm6-TeNT, and GAD1KO retina.
(C) Electron micrographs showing dyad synapses between RBC boutons
(cyan) and AII (purple) and A17 (pink) amacrine cell processes in the wild-type,
grm6-TeNT, and GAD1KO retinae at P15 and P30–P35. Presynaptic ribbons
are indicated by arrows. Asterisks mark examples of A17 contact. Note that
RBCs in the P30 grm6-TeNT retina have multiple ribbons at a single dyad
synapse.
See also Figure S3.
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Presynaptic Inhibition on Axonal Terminalsto GAD65 containing processes (Figure 1C), suggesting that
GAD67-positive amacrine cell processes provide the majority
of GABAergic inhibition onto RBC axon terminals.
To visualize amacrine cell contacts onto RBC terminals during
development, we utilized the GAD67-GFP transgenic line (Chat-
topadhyaya et al., 2004), where a fraction of GAD67-positive
amacrine cells (Figure S1A available online) express GFP. Ama-
crine cells typically synapse onto bipolar cell axons at enlarged
varicosities (Dowling and Boycott, 1966). Using the GAD67-
GFP transgenic line, we visualized large varicosities of GFP-
labeled amacrine processes contacting RBC boutons at sites
immunopositive for GAD67, but not GAD65 (Figure S1B). We
further determined when GABAergic contacts develop on
RBCs, labeled by expression of the fluorescent protein tdtomato
under the grm6 promoter (Figure 1D). Appositions between
GAD67-GFP positive processes and RBC axonal boutons were
already apparent at postnatal day (P) 10 (Figure 1D), several
days after axonal differentiation in the bipolar cells (Morgan126 Neuron 78, 124–137, April 10, 2013 ª2013 Elsevier Inc.et al., 2006). At P15, large varicosities were clearly present at
sites of contact between amacrine cell dendrites and RBC
boutons, which remained evident at P21. We previously found
that spontaneous GABAergic inhibitory postsynaptic currents
(sIPSCs) can be recorded from RBCs from P10 (Schubert
et al., 2008). Thus, the appearance of structural contacts be-
tween GABAergic amacrine cells and RBC axon terminals coin-
cides with the emergence of sIPSCs in RBCs. This suggests that
functional postsynaptic GABA receptor clusters are already pre-
sent on RBC terminals before eye opening (P15).
Previous studies demonstrated that GABAA and GABAC re-
ceptors are present on axon terminals of RBCs across species
(Fletcher et al., 1998; Koulen et al., 1997, 1998; Lukasiewicz,
1996, 2004; Enz et al., 1996; McCall et al., 2002). To monitor
the appearance of GABA receptor clusters on RBC axonal bou-
tons during circuit assembly, we labeled for GABAA and GABAC
receptors at two developmental time points, before eye opening
(P12) and at maturity (P30). We found abundant GABAC receptor
clusters on PKC-labeled axon terminals of RBCs as early as P12
and at P30 (Figures 1E and 1F). To determine the subunit compo-
sition of the GABAA receptor clusters located at these terminals,
we performed immunostaining for GABAA a1–a3 subunits
together with PKC. a2-containing GABAA receptors were not
present on RBC axon terminals (Figure S2A), supporting past
findings (Fletcher et al., 1998). In contrast, both a1- and a3-con-
taining GABAA receptor clusters were localized on RBC axonal
boutons at both ages examined (Figures 1E and 1F). GABAA
synapses containing a1 or a3 subunits did not colocalize with
GABAC receptors (Figure S2B) as found previously in adult retina
(Koulen et al., 1996; Wa¨ssle et al., 1998). Furthermore, these
three GABA receptor cluster types (a1-GABAA, a3-GABAA, and
GABAC) on RBC boutons were each apposed to large GAD67-
GFP amacrine cell varicosities (Figure S1C). Coimmunolabeling
for GAD67 and GABA receptors revealed that 93.27% ± 0.48%
of GABAAa1 (n = 2 animals), 93.89% ± 0.66% of GABAC
(n = 2), and 79.30% ± 2.04% of GABAAa3 (n = 3) receptor
clusters on RBC terminals were apposed to GAD67-positive
terminals. Thus, all three GABA receptor types are present on
RBC terminals before eye opening, suggesting that synapses
comprising these receptor types develop concurrently.
Synaptic Contacts between RBCs and Amacrine Cells
Form Despite Reduction of GABAergic or Glutamatergic
Neurotransmission
To determine the role of neurotransmission in the structural
development of inhibitory synapses onto RBC axon terminals,
we used two transgenic mouse lines (Figure 2A). First, we asked
whether suppressing glutamatergic transmission onto amacrine
cells that likely contact RBCs affects the development of ama-
crine cell synapses onto RBC axons. This was achieved using
the grm6-TeNT line in which neurotransmission from all ON-
bipolar cells, including RBCs, is suppressed by expression of
the light chain of tetanus toxin (Kerschensteiner et al., 2009).
Next, we assessed the outcome when GABA release from ama-
crine cells is diminished from development onward. To do so, we
crossedGAD1 conditional knockout (KO) mice (Chattopadhyaya
et al., 2004) with aPax6-Cre mice in which cre-recombinase
expression is limited to the retina, to generate GAD1KO mice
Neuron
Presynaptic Inhibition on Axonal Terminals(Schubert et al., 2010) (Figure S3). InGAD1KO retina, the level of
GAD67 expression is reduced (Figure S3A), and immunolabeling
for GAD67 reveals that loss of GAD67 (in the knockout region)
occurs outside a dorsal-ventral strip (the WT region) in which
cre-recombinase is largely absent (Figures S3B and S3C; see
Marquardt et al., 2001). We use ‘‘GAD1KO’’ from here on to refer
to the knockout regions.
We compared vesicular inhibitory amino acid transporter
(VIAAT) immunolabeling across wild-type, grm6-TeNT, and
GAD1KO retinas to assess whether amacrine cell terminals sur-
rounding RBC axons failed to differentiate when neurotransmis-
sion is perturbed. We found no gross changes in the density of
VIAAT labeling surrounding P30 RBC axonal terminals in either
transgenic line, suggesting that amacrine cell-RBC synapses
still formed (Figure 2B). We confirmed that amacrine cell-RBC
synapses still formed in the mutant mice, by examining the ultra-
structural arrangement of RBC axonal boutons in both grm6-
TeNT and GAD1KO retina. In both lines, amacrine cells still syn-
apsed onto RBC boutons, and these synapses were apparent
at eye opening (P15) (n = 14GAD1KO; n = 26 TeNTRBC boutons
examined) as in wild-type animals (Figure 2C). However, some
aspects of the synaptic arrangements differed between grm6-
TeNT and GAD1KO retinas. P30 RBC boutons formed dyad
synapses at sites containing a single ribbon in the GAD1KO
(n = 20 RBC synapses per genotype), but such arrangements
were disrupted in grm6-TeNT retinas, where sometimes multiple
ribbons were apposed to a single postsynaptic density (n = 16 of
26 at P15, and 13 of 23 synaptic sites had >1 ribbon at P30; e.g.,
Figure 2C), as shown previously (Kerschensteiner et al., 2009).
Thus, although the ribbon arrangement of the RBC is differen-
tially affected in grm6-TeNT and GAD1KO retinas, the amacrine
cell-RBC synapse forms and ismaintained regardless of whether
bipolar or amacrine cell transmission is perturbed.
Development and Maintenance of GABAergic Synapses
on RBC Axon Terminals Do Not Rely on Glutamatergic
Transmission
Although amacrine cell synapses are present structurally on RBC
terminals in grm6-TeNT retinas, it is possible that suppression
of glutamatergic drive from bipolar cells leads to alterations
in GABA-mediated transmission onto RBC axon terminals. We
thus performed whole-cell recordings on wild-type and grm6-
TeNT RBCs and analyzed spontaneous GABAergic inhibitory
postsynaptic currents (sIPSCs) (Figure 3A). Spontaneous IPSCs
in both genotypes were comparable in mean frequency and
amplitude at both P11–P13 and P30, indicating that the number
of GABAergic synaptic contacts and the size of postsynaptic
GABA receptor clusters were not significantly affected by a
reduction of glutamatergic input to amacrine cells (Figure 3B).
To evoke release of GABA from presynaptic amacrine cells, we
puffed a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
(AMPA) at the axon terminal of RBCs (Cha´vez et al., 2006) and re-
corded the evoked PSCs at 0 mV holding potential (Figure 3C).
The mean charge of AMPA-evoked currents was not different
in wild-type and grm6-TeNT RBCs at both P11–P13 and P30
(Figure S4). To distinguish GABAA and GABAC components of
the evoked response, AMPApuffs were repeated in the presence
of (1,2,5,6-tetrahydropyridine-4yl) methyphospinic acid (TPMPA)(GABAC receptor antagonist) or SR95531 (GABAA receptor anta-
gonist) (Figure 3C). Quantification of mean charge and ampli-
tude (data not shown) of the evoked response (total, GABAA, or
GABAC) showed no significant differences between RBCs in
wild-type and grm6-TeNT retinas at P11–P13 (Figure 3D) and at
P30 (Figure 3E). Together, these results suggest that functional
GABAergic synapses are formed normally and maintained even
when the bipolar cells fail to transmit effectively to amacrine cells.
RBC Responses to GABA Application Decline
with Maturation in the GAD1 Mutant
To assess the functional consequences of reduced GABA syn-
thesis on the formation and maintenance of inhibitory synapses
onto RBC axon terminals, we performedwhole-cell recordings of
these neurons in theGAD1KO retina. As expected, spontaneous
inhibitory postsynaptic currents (sIPSCs) were rare in GAD1KO
at both ages examined (Figures 4A and 4B). This indicates that
deletion of GAD67was not accompanied by a compensatory up-
regulation of the other GABA synthesizing enzyme, GAD65.
Because synaptic release of GABA in these mutants is greatly
impaired, we puffed GABA onto GAD1KO RBC axon terminals
and recorded the evoked chloride currents in order to assess
whether any postsynaptic changes occurred in GAD1KO
RBCs. Interestingly, RBC responses to GABA application in
GAD1KO were unchanged at P11–P13 but were dramatically
reduced at P30 (example recordings in Figure 4C). Both mean
amplitude and charge of the evoked responses decreased
by P30 (Figure 4D). Moreover, the rise time was slower for
evoked responses in P30 GAD1KO RBCs, whereas their decay
time was faster, as compared to control (Figure 4E). Thus,
GABAergic transmission plays an important role in the main-
tenance, although not in the initial formation, of functional
GABAergic synapses on RBC axon terminals.
In wild-type animals, RBCs receive little glycinergic input (Eg-
gers et al., 2007). Indeed, immunolabeling for the a1 or a2 sub-
unit of the glycine receptor (Ivanova and Mu¨ller, 2006; Wa¨ssle
et al., 2009) showed little glycine receptor expression on RBC
axon terminals (Figures S5A and S5B). However, a severe reduc-
tion of GABAergic transmission in GAD1KO may be compen-
sated for by an upregulation of glycine receptor-driven input
onto RBC axon terminals. We investigated this possibility by
quantifying the expression of glycine receptors containing a1
or a2 subunits on RBC axon terminals in GAD1KO retina. But,
we did not find any upregulation of these glycine receptor sub-
types in the RBC terminals of GAD1KO (Figure S6).
GABAA and GABAC Receptors on RBC Axon Terminals
Are Differentially Altered in GAD1KO
Because GABAA and GABAC receptor clusters are found at
distinct postsynaptic sites on RBC axon terminals, we next
asked whether loss of GABAergic transmission affected both re-
ceptor types. Figure 5A shows examples of the GABA-evoked
responses of P30 RBCs from a littermate control and aGAD1KO
animal in which the GABAA component is revealed upon block-
ing the GABAC receptor-mediated current. Quantification of
themean amplitude and charge of the evoked GABAA responses
in RBCs revealed significant reduction in the knockout animal
(Figure 5B). Similarly, the evoked GABAC responses wereNeuron 78, 124–137, April 10, 2013 ª2013 Elsevier Inc. 127
Figure 3. Spontaneous and GABA-Evoked
Currents of RBCs in grm6-TeNT Retina
(A) Spontaneous GABAergic currents recorded in
grm6-TeNT and wild-type (WT) RBCs at P11–P13
and P30.
(B) Quantification revealed no significant differ-
ences in either the mean frequency or mean
amplitude of GABAergic sIPSCs from grm6-TeNT
RBCs as compared to WT.
(C) Example traces showing chloride-mediated
outward currents in RBCs evoked by AMPA puffs
in grm6-TeNT and WT RBCs at both ages. The
GABAC component was isolated by application of
TPMPA and residual GABAA-mediated current
blocked by SR95531.
(D and E) Scatter plots show that the mean charge
transfers of the total, GABAA-mediated, and
GABAC-mediated currents are comparable be-
tween grm6-TeNT and WT RBCs at P11–P13 (D)
and P30 (E). Bracketed numbers in (B), (D), and (E)
represent the number of cells. Error bars repre-
sent SEM.
See also Figure S4.
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currents (Figure 5C). In contrast to GABAA-mediated responses,
the mean amplitude of the GABAC-mediated response was
unchanged (Figure 5D). However, the net charge carried by the
GABAC currents was significantly reduced in GAD1 (Figure 5D).
This may reflect faster GABAC-mediated response kinetics in
RBCs from GAD1KO compared to littermate control (see
Figure 4E).
To correlate these functional changes at P30 with the expres-
sion of GABAA and GABAC receptor types, we immunostained
for the a1 and a3 subunits of theGABAA receptors and the r sub-128 Neuron 78, 124–137, April 10, 2013 ª2013 Elsevier Inc.units of the GABAC receptors. We
compared the immunolabeling of P30
knockout regions in the GAD1 mutant
with corresponding wild-type regions
(which provides an ideal control because
these regions are within the same retina)
as well as with littermate control retinas.
For GABAA receptors, GAD67 immuno-
staining was used to distinguish knockout
regions from wild-type regions in
GAD1KO (Figures 6A and 6B). However,
we could not colabel GAD67 and
GABAC receptors due to species speci-
ficity of the antibodies. Instead, we used
the GFP signal to identify the knockout
regions because GFP is expressed
specifically in cells in which the GAD1
exon is excised (Marquardt et al., 2001).
Overall, immunoreactivity for a1-contain-
ing GABAA receptors was significantly
reduced in the knockout region com-
pared to the wild-type region and litter-
mate control (Figure 6A). In contrast,
a3-containing GABAA receptor labelingdid not appear to have changed in the knockout regions (Fig-
ure 6B). Similarly, GABAC receptor staining was comparable
across regions and genotypes (Figure 6C). Because of the high
density of GABA receptor clusters on RBC boutons, it was not
always possible to separate individual clusters. Thus, instead
of determining the number of receptor puncta, we quantified
the percent volume occupied by each receptor subtype on
PKC-positive RBC boutons (see Experimental Procedures). We
found that the percent volume occupied by a1-containing
GABAA receptors, but not a3-containing GABAA receptors or
GABAC receptors, was significantly reduced in the knockout
Figure 4. Spontaneous and GABA-Evoked
Currents of RBCs in GAD1KO Retina
(A) Spontaneous GABAergic IPSCs at RBC axon
terminals recorded from GAD1KO and littermate
control (ctr) at P11–P13 and P30.
(B) Scatter plots show that the mean frequency
of these sIPSCs is reduced in GAD1KO as com-
pared to ctr.
(C) Puffs of GABA evoke similar chloride-mediated
outward currents in RBCs from ctr andGAD1KO at
P11–P13, which are markedly reduced for
GAD1KO RBCs at P30.
(D) Quantification reveals a significant reduction
for both the mean peak amplitude and charge
of GABA-evoked currents from GAD1KO RBCs
at P30.
(E) In addition, the rise time for the P30-evoked
response from GAD1KO RBCs is longer, whereas
the decay is faster as compared to control.
Bracketed numbers in (B), (D), and (E) represent
the number of cells. Asterisks mark significant
difference. Error bars represent SEM.
See also Figure S3.
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Presynaptic Inhibition on Axonal Terminalsregions (Figure 6). This reduction of GABAAa1 clusters in GAD67-
deficient regions was corroborated by using another GABAAa1
antibody raised in a different species (Figure S6A). To assess
whether GABAAa1 synthesis levels inGAD1KO retina was dimin-
ished overall, we performed western blot analysis using P30
retina homogenates from which the dorsal-ventral wedge was
removed. The total GABAAa1 synthesis levels in the GAD1KO
mutant was comparable to littermate control samples (Fig-
ure S6B; n = 2 GAD1KO and 2 littermate controls), suggesting
that overall synthesis of GABAAa1 receptors in GAD67-deficient
retina was unchanged. The reduction in immunostaining for
GABAAa1 in the GAD1KO is thus unlikely to be caused by an
alteration in receptor synthesis and is more likely the result of a
deficit in the maintenance of GABAAa1 clusters on RBC termi-
nals. Because we found little expression of the known inhibitoryNeuron 78, 124–1postsynaptic scaffolding proteins, Neuro-
ligin2 and Gephyrin, at GABAA receptors
in RBC axon terminals (Figures S5B and
S5C), we decided against analyzing the
expression levels of these proteins in
GAD1KO RBCs. Taken together, our
findings demonstrate that GABAA and
GABAC receptors on RBC axon termi-
nals are differentially maintained by
GABAergic transmission.
The specific reduction of GABAA and
not GABAC receptor clusters in GAD1KO
RBCs suggests an independent regula-
tion of the maintenance of these two
ionotropic GABA receptor types that
coexist on the same axonal terminal. To
further test this hypothesis, we immunola-
beled a1-containing GABAA receptor
clusters in GABACKO mice (McCall
et al., 2002) (Figure S7). We found noalteration in the percent volume occupied by a1-containing
GABAA receptors in P30 GABACKO RBC terminals (Figure S7).
Thus, we conclude that there exists independent regulatory
mechanisms for maintaining GABAA and GABAC receptor clus-
ters on RBC axon terminals.
Reduced GABAergic Drive Transiently Increases
Glutamate Release from Developing RBCs
GABAergic A17 amacrine cells form reciprocal synapses with
glutamatergic RBCs.We thuswonderedwhether there were cor-
responding changes in the RBC input onto the A17 cells in
GAD1KO. We compared RBC input onto A17 cells in GAD1KO
with wild-type littermate controls at two developmental time
points, P11–P13 and P30, by recording spontaneous excitatory
postsynaptic currents (sEPSCs) from A17 amacrine cells. In37, April 10, 2013 ª2013 Elsevier Inc. 129
Figure 5. GABAA and GABAC Receptor-Mediated Currents from P30
RBCs in GAD1KO Retina
(A) Example traces of P30GAD1KO and littermate control (ctr) RBC responses
to GABA puffs. TPMPA was applied to isolate the GABAA-mediated compo-
nent. Further addition of SR95531 blocked all evoked response.
(B) Scatter plots show that mean peak amplitude and charge of GABAA-medi-
ated currents in GAD1KO RBCs are significantly reduced as compared to ctr.
(C) Application of SR95531 alone isolates the GABAC-mediated component of
evoked responses in RBCs.
(D) Quantification of GABAC-mediated currents indicates a significant reduc-
tion of the mean charge in GAD1KO RBCs as compared to ctr. However, the
mean amplitude remained unchanged. Bracketed numbers in (B) and (D)
represent the number of cells. Asterisks mark significant difference. Error bars
represent SEM.
See also Figure S3.
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Presynaptic Inhibition on Axonal Terminalslittermate controls, themean frequency of sEPSCs in these ama-
crine cells normally increased with age (Figures 7A and 7B). In
GAD1KO, the mean frequency of sEPSCs from A17 amacrine
cells at P11–P13 was significantly higher compared to their con-
trol littermates (Figures 7A and 7B). In the KO, there was no
further increase in sEPSCs frequency in the A17 cells with matu-
ration (Figures 7A and 7B), and in fact, the P11–P13 sEPSCs
were already comparable to that of P30 controls. These observa-
tions together suggest that although the RBC output is initially130 Neuron 78, 124–137, April 10, 2013 ª2013 Elsevier Inc.elevated during development when inhibition is reduced,
homeostatic mechanisms ensure that the bipolar cell output
operates within its normal range at maturity (Figure 7B).
Is the transient increase in frequency of the sEPSCs from
developing A17 cells in the KO simply a result of reduced inhibi-
tion onto the RBC axonal terminals? To answer this, we recorded
sEPSCs from A17s in P11–P13 GAD1KO and littermate control
animals in the presence of GABAA and GABAC receptor
blockers, SR95531 and TPMPA, respectively (Figure 7C). Even
in the presence of GABA receptor blockers, P11–P13 A17 cells
showed an increased frequency of sEPSCs in GAD1KO as
compared to control (Figure 7C), suggesting that there is an
upregulation of glutamatergic drive onto A17 cells in GAD1KO.
This upregulation, however, is not the consequence of per-
turbed GABAC-receptor mediated transmission, despite GABAC
receptors carrying the majority of the total charge transfer (Fig-
ures 5B and 5D; Eggers and Lukasiewicz, 2006a; McCall et al.,
2002). In the presence of a GABAA receptor antagonist, the
mean sEPSC frequency of P11–P13 A17 cells in the GABAC
receptor KO is not significantly different from that of littermate
controls (Figure S8).
Could the upregulation of glutamatergic drive onto developing
A17 cells be due to changes in receptor density on A17 cells?We
found that at P11–P13, the mean amplitude of the sEPSCs was
unchanged for A17s in GAD1KO (Figures 7D and 7E), indicating
that the glutamate receptor density at individual postsynaptic
sites is not altered. Also, A17 cell responses to AMPA puffs re-
vealed no differences between GAD1KO and control (Figures
7F and 7G). Thus, the total density (or number) of glutamatergic
synapses on A17s is unperturbed in GAD1KO animals (Figures
7D–7G). This suggests that the increase in A17 sEPSC mean
frequency in GAD1KO is not the result of changes in glutamate
receptor density on the A17 cell but is more likely due to presyn-
aptic changes, such as the probability of release, in the RBC
terminal.
DISCUSSION
We found that RBC axon terminals receive GABAergic inhibition
from GAD67-positive amacrine cells via three distinct GABA
receptor subtypes (GABAAa1, GABAAa3, and GABAC). Using
mutant mice, we found that GABAergic synapses are still estab-
lished on RBC axonal terminals when either glutamatergic or
GABAergic transmission is perturbed. However, the mainte-
nance of GABAAa1 receptor clusters on RBC axonal terminals
is selectively disturbed when GABA synthesis is much reduced
in the presynaptic amacrine cells (Figure 8). Further, the mainte-
nance of GABAAa1 receptor clusters is not dependent on
the presence or synaptic drive via GABAC receptors. We also
discovered that glutamate release from developing RBCs
increased in the GAD1KO, but not in the GABACKO retinas
(Figure 8).
GABAergic Synapse Maintenance, but Not Formation,
on Axon Terminals Is Influenced by GABAergic
Transmission
How neurotransmission modulates the formation of inhibitory
synapses has primarily been addressed for synapses onto
Figure 6. GABAA Receptor Subsets on
Mature RBC Boutons in GAD1KO Retina
(A) Triple immunolabeling of PKC expressing
RBCs (blue), GAD67 (red), and GABAAa1 subunits
(yellow) revealed a visible reduction of a1-con-
taining GABAA receptor clusters in the KO region
of GAD1KO retina, compared to the WT region or
littermate control. Quantification of the percent
volume occupied by GABAAa1 clusters on PKC-
positive boutons confirmed a significant reduction
in the KO region.
(B) Immunostaining for the GABAAa3 receptor
subunit revealed no significant differences in
the percent volume occupied by these receptor
clusters on KO region RBC boutons.
(C) Immunolabeling and percent volume occu-
pancy of GABACr receptor subunits were com-
parable across littermate control, WT regions, and
KO regions. Bracketed numbers represent the
number of animals. Asterisks mark significant
difference. Error bars represent SEM.
See also Figures S3, S5, S6, and S7.
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Presynaptic Inhibition on Axonal Terminalssomata and dendrites of neurons (Chattopadhyaya et al., 2007;
Hartman et al., 2006; Harms and Craig, 2005; Kilman et al.,
2002). Recently, GABAergic transmission was found to regulate
the maturation of basket interneuron axonal terminals (Fu et al.,
2012). Here, we assessed the importance of neurotransmission
in the development of GABAergic synapses on glutamatergic
axon terminals, focusing on amacrine cell-RBC connectivity.
Our results demonstrate that presynaptic GABAergic amacrine
cells do not require glutamatergic drive from bipolar cells to
establish their inhibitory synapses onto bipolar cell axons.Neuron 78, 124–1GABA release onto RBCs as well as
GABA receptor density of RBCs are un-
changed in the grm6-TeNT retinas. This
is in contrast to a reduced number of
inhibitory synapses and decrease in syn-
aptic vesicle density of terminals contact-
ing the dendrites of spinal cord neurons
cultured in the presence of glutamate
(non-NMDA) receptor antagonists (Ro-
sato-Siri et al., 2002).
Prior work has demonstrated that
GABAergic transmission is not essential
for inhibitory synapse formation on den-
drites and somas per se (Chattopad-
hyaya et al., 2007; Wojcik et al., 2006;
Wu et al., 2012). We found this to also
be true for inhibitory synapse formation
onto axon terminals as amacrine cell-
RBC synapses are evident in the
retinal-specific GAD1KO. Reduction of
GAD67 in basket cells of the visual cor-
tex, however, results in fewer periso-
matic inhibitory synapses on pyramidal
neurons (Chattopadhyaya et al., 2007).
This reduction in inhibitory synapse
number onto the cell bodies appears tobe due to the lack of GABAergic transmission during syn-
aptogenesis, rather than a failure to maintain established syn-
apses. In the retina, we found that reducing GABAergic
transmission during development affects the maintenance
of GABA receptors on the RBC axons, but not the initial forma-
tion of these synapses. From previous work (Burrone and
Murthy, 2003; Pozo and Goda, 2010; Turrigiano, 2007), we
had expected that RBCs in GAD1KO might undergo homeo-
static adjustment and recruit more GABA receptors to their
axons to compensate for reduced GABAergic transmission.37, April 10, 2013 ª2013 Elsevier Inc. 131
Figure 7. RBC Output Is Transiently In-
creased in GAD1KO Retina during Circuit
Development
(A) sEPSCs recorded from A17 amacrine cells at
P13 and P30 in GAD1KO and littermate control
(ctr) retina show an increase during normal devel-
opment.
(B) The sEPSC frequency was increased for A17
amacrine cells in GAD1KO as compared to ctr
early in development at P13 but was comparable
to control at P30.
(C) Mean frequency of sEPSCs from P11–P13 A17
amacrine cells in GAD1KO and ctr in the presence
of GABA receptor antagonists TPMPA and
SR95531 also show increased frequency in the
GAD1KO.
(D) Mean sEPSC amplitudes recorded in A17s
from littermate control and GAD1KO at P11–P13
and P30 reveal no differences.
(E) Mean amplitude of sEPSCs recorded from
P11–P13 A17 amacrine cells in GAD1KO and ctr
in the presence of GABA receptor antagonists
TPMPA and SR95531 show no difference.
(F) Example traces showing AMPA-evoked cation-
mediated inward currents from A17 cells clamped
at 60 mV in ctr and GAD1KO at P11–P13.
(G) Scatter plots show that the mean amplitude
is comparable between genotypes. Bracketed
numbers represent the number of cells. Asterisk
marks significant difference. Error bars repre-
sent SEM.
See also Figures S3 and S8.
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Presynaptic Inhibition on Axonal TerminalsInstead, we observed that RBC axon terminals lose GABA re-
ceptors at maturity when presynaptic GABA release is reduced
chronically.
Activity-Dependent Maintenance of Axonal GABA
Receptors Is Receptor Subtype Specific
To date, most studies focusing on the activity-dependent main-
tenance of GABAA receptors in neurons have assessed the
distribution of the entire GABAA receptor population, irrespective
of their subunit composition. This is because in most parts of the
nervous system, GABAA receptors can comprise mixed a sub-
units together with b and g subunits (Fritschy and Mohler,
1995; Kasugai et al., 2010). However, in the mammalian retina,
three distinct subtypes of GABAA receptors can be distinguished
by the presence of specific a subunits (a1–a3) localized at
nonoverlapping synapses (Koulen et al., 1996; Wa¨ssle et al.,
1998). On mouse RBC axon terminals, we identified two types
of GABAA receptor synapses, containing either the a1 or a3
subunit. Both these GABAA receptor types were apposed to
GAD67-positive processes but, functionally, they could provide
GABAA receptor-mediated inhibition with different time courses,
because a1-containing GABAA receptors exhibit faster response132 Neuron 78, 124–137, April 10, 2013 ª2013 Elsevier Inc.kinetics compared to a3-containing re-
ceptors (Gingrich et al., 1995; Ortinski
et al., 2004; Vicini et al., 2001). Surpris-
ingly, we found that reduced GABAergic
neurotransmission selectively regulatedthe maintenance of GABAAa1, but not GABAAa3, receptor
clusters.
Reducing GABAergic transmission also differentially affected
the maintenance of the two ionotropic GABA receptor types
(GABAA and GABAC) on RBC axons. Whereas the amplitude of
the GABAA receptor component of the GABA-evoked response
was decreased at P30 in GAD1KO, there was no change in
amplitude of the GABAC component. Our immunostaining for
GABAA and GABAC receptors supported this differential reduc-
tion in GABAA versus GABAC receptors on RBC axons. What
might be the differences in GABAA and GABAC receptors
that could account for this differential outcome in the GAD1KO?
GABAC receptors have a higher affinity for GABA compared to
GABAA receptors (Feigenspan and Bormann, 1994). Perhaps
these receptors require only low levels of GABA for their mainte-
nance. GABAA and GABAC receptors do not colocalize at the
same postsynaptic sites (Fletcher et al., 1998; Koulen et al.,
1998). Thus, it could also be that these two GABA receptor types
are differentially positioned on the RBC terminal relative to the
GABA release site, such that GABAA receptors normally ‘‘sense’’
higherGABA levels compared toGABAC receptors and thusneed
a substantial amount of GABA in the synaptic cleft for their
Figure 8. Summary of the Alterations in
RBC-A17 Synapses in GABAergic Tansmis-
sion-Defective Mutants before and after
Eye Opening
Schematic illustrating the A17-RBC synapse
before and after eye opening in wild-type,
GAD1KO, and GABACKO retina. GABA and
glutamate release are similar between wild-type
and GABACKO (see also Eggers and Lukasiewicz,
2006a) but is altered in GAD1KO. There is a tran-
sient upregulation of glutamate release from
developing RBCs in GAD1KO before eye opening.
However, after eye opening, glutamate release
from RBCs in GAD1KO becomes comparable to
wild-type. GABAA, and not GABAC, receptors are
selectively reduced at maturity in GAD1KO. This
reduction of GABAA receptors on RBCs does not
occur in GABAC receptor mutants.
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Presynaptic Inhibition on Axonal Terminalsmaintenance. We further showed that loss of GABAC receptors
per se does not affect the maintenance of GABAAa1 receptors
in RBC terminals. We found no downregulation of GABAA recep-
tors in GABACKO retina. Furthermore, in GABACKO retina, the
function of glycine receptors (Eggers and Lukasiewicz, 2006a)
on RBCs axon terminals is not affected. Accordingly, inGAD1KO
we found no upregulation of glycine receptor clusters on RBC
axon terminals. Taken together, our observations highlight inde-
pendent mechanisms for regulating the distribution and density
of distinct inhibitory receptor types (GABA receptors versus
glycine receptors, GABAA versus GABAC receptors, and
GABAAa1 versus GABAAa3 receptor types) on the same RBC
axon terminal.
What underlies the eventual reduction of a1-containing
GABAA receptors in GAD1KO? The role of activity in inhibitory
receptor accumulation has been addressed in spinal cord cul-
tures, where blocking neuronal activity by tetrodotoxin (TTX)
application prevented glycine receptor accumulation (Kirsch
and Betz, 1998). However, our physiological recordings suggest
that GABA receptors accrue normally on RBC axons initially
(P11–P13), and total GABAAa1 synthesis in adult (P30) GAD1KO
retina also appeared unimpaired. Another possibility is a failure
to stabilize GABAAa1 receptor clusters after they have formed
at synapses (Saliba et al., 2007). Tracking movements of
the inhibitory postsynaptic scaffold protein gephyrin in dissoci-
ated spinal cord neurons previously demonstrated activity-
dependent stabilizations of the gephyrin-fluorescent protein
conjugates at synaptic versus extrasynaptic locations (Hanus
et al., 2006). The phenotypic alterations we observed in density
of a1-containing GABAA receptors on RBC axons in GAD1KO
could be a result of failed stabilizations of GABAA receptors
at this synapse. This could lead to greater receptor internali-
zation and subsequent degradation detectable as reduced
receptor volume occupancy. Indeed, blocking neuronal activity
has been shown previously to induce ubiquitination and degra-
dation of GABAA receptors (Luscher et al., 2011). However,
because Neuroligin2 and Gephyrin do not appear to be at allGABAAa1 receptor clusters on the RBCs, future work is
necessary to identify the postsynaptic scaffold proteins at the
RBC axonal GABA receptors before we can systematically
investigate the molecular mechanisms underlying the loss
of GABAAa1 receptor clusters on RBC axon terminals in the
GAD1 mutant.
RBCs Adjust Their Output Homeostatically in Response
to Reduced GABAergic Drive
We found that RBCs increase their output onto A17 amacrine
cells with maturation. Our study shows that this output is
structurally and functionally modified by alterations in neuro-
transmission during development and circuit maturation. When
glutamate release fromRBCs is suppressed by TeNT expression
in these cells, more ribbons are often recruited to RBC output
sites. When GABAergic transmission is impaired, glutamate
release from developing RBC terminals is increased beyond
that expected solely from disinhibition in the GABA-deficient
circuit, perhaps as an attempt to facilitate GABA release from
the ‘‘silenced’’ A17 amacrine cells with which it shares a recip-
rocal synapse. Interestingly, this increase in glutamate release
in developing RBCs in GAD1KO retinas does not appear to
evoke a change in glutamate receptor density on the A17 ama-
crine cell. The lack of a complementary change in the A17 cell
is unexpected for two reasons: (1) the RBC-A17 synapse is
bidirectional, and (2) in other systems, downregulation of post-
synaptic glutamate receptors occurs when there is enhanced
presynaptic glutamate release due to homeostatic mechanisms
coming into play (Burrone and Murthy, 2003; Pozo and Goda,
2010; Turrigiano, 2007). In GAD1KO, RBC output further un-
dergoes homeostatic regulation with maturation to ‘‘cap’’ or limit
its output with circuit maturation, perhaps to maintain normal
processing in the scotopic pathway involving the other postsyn-
aptic partner, the AII amacrine cell (Bloomfield and Dacheux,
2001). This later homeostatic regulation of RBC output parallels
the loss of GABAA receptors on RBCs, but these events are
unlikely to be related. This is because the progressive loss ofNeuron 78, 124–137, April 10, 2013 ª2013 Elsevier Inc. 133
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Presynaptic Inhibition on Axonal TerminalsGABA receptors does not affect inhibition on RBCs as there is
little GABA release in GAD1KO. Our results highlight divergent
mechanisms behind the regulation of output from RBC axon
terminals and GABA receptor maintenance on these terminals.
Our current findings also underscore the importance of assess-
ing changes in GABA receptors on axons in addition to the
somata and dendrites of neurons for understanding neurodeve-
lopmental disorders, such as schizophrenia, where GABAergic




Several transgenic mouse lines were used in this study. In the GAD67-GFP
(G42) line, the GAD67 promoter drives GFP expression in a fraction of
GABAergic amacrine cells (Chattopadhyaya et al., 2004). In the grm6-
tdtomatomouse line, the red fluorescent protein tdtomato is expressed specif-
ically by ON-bipolar cells under the mGluR6 promoter (Kerschensteiner et al.,
2009). In GAD1/lox/lox mice (Chattopadhyaya et al., 2007), exon 2 of GAD1,
the gene encoding GAD67 (Bu et al., 1992), is flanked by loxP sites. To obtain
retina-specific excision of exon 2, this line was bred to the a-Cre line, in which
Cre-recombinase expression is regulated by the alpha enhancer of the Pax6
promoter (Marquardt et al., 2001). The excision of exon 2 in cells expressing
Cre-recombinase results in a frameshift mutation of GAD1 (Chattopadhyaya
et al., 2007). We refer to this double transgenic line as GAD1KO. To abolish
glutamatergic transmission in RBCs, we used grm6-TeNT transgenic in which
the light chain of tetanus toxin is expressed specifically in ON-bipolar cells
(Kerschensteiner et al., 2009). To eliminate GABAC receptors from the retina,
the gene encoding GABACr1 subunit was inactivated (McCall et al., 2002);
we refer to these mice as GABACKO.
Immunohistochemistry
Animal protocols were approved by the Institutional Animal Care and Use
Committee at the University ofWashington. All procedureswere in compliance
with the National Institutes of Health Guide for the Care and Use of Laboratory
Animals. Mice deeply anaesthetized with Isoflurane were decapitated and
enucleated. The cornea was puncturedwith a 30 gauge needle, and the retinas
were removed in cold oxygenated mouse artificial cerebrospinal fluid (mACSF
[pH 7.4]) containing (in mM) 119 NaCl, 2.5 KCl, 2.5 CaCl2, 1.3 MgCl2, 1
NaH2PO4, 11 glucose, and 20 HEPES. For vibratome sectioning, the retina
was fixed for 20 min in 4% paraformaldehyde in mACSF (pH 7.4). For fixed
flat-mount preparations, retinas were isolated and mounted retinal ganglion
cell side up on black membrane filters (HABP013, Millipore, Billerica, MA,
USA). The retina and filter paper were then immersed in 4% paraformaldehyde
in mACSF (pH 7.4) for either 15 min (for GABAAa1 and GABAAa3 immunolab-
eling) or 30 min (for GABAC labeling). After fixation, the tissue was washed in
0.1 M PBS (pH 7.4), preincubated in PBS containing 5% normal donkey serum
(NDS) and 0.5% Triton X-100, and incubated with primary antibodies in the
same solution. For retinal whole-mounts, primary antibody incubation was
performed over three nights. Secondary antibody incubation was carried out
in PBS, and retinas were subsequently mounted in Vectashield (Vector Labs,
Burlingame, CA, USA). Immunolabeling was performed using antibodies
against PKC (rabbit polyclonal, 1:1,000, Chemicon, Temecula, CA, USA, or
mouse monoclonal, 1:1,000, Sigma-Aldrich, St. Louis), GAD67 (mouse mono-
clonal, 1:1,000, Chemicon), GAD65 (rabbit polyclonal, 1:1,000, Chemicon),
VIAAT (guinea pig polyclonal, 1:1,000, Synaptic Systems, Goettingen, Ger-
many), GFP (chicken polyclonal, 1:1,000, Abcam, Cambridge, UK), Glycine
receptor a1 subunit (mouse monoclonal mAb2b, 1:500, Synaptic Systems),
Glycine receptor a2 subunit (goat polyclonal, 1:300, Santa Cruz Biotech-
nology, Santa Cruz, CA, USA), Gephyrin (mouse monoclonal 3B11, 1:1,000,
Synaptic Systems), Neuroligin2 (rabbit polyclonal, 1:4,000, kindly provided
by F. Varoqueaux and N. Brose), GABACr receptor subunit (rabbit polyclonal,
1:500, kindly provided by R. Enz), GABAAa1 receptor subunit (polyclonal
guinea-pig, 1:5,000, kindly provided by J.M. Fritschy), GABAAa1 receptor134 Neuron 78, 124–137, April 10, 2013 ª2013 Elsevier Inc.subunit (polyclonal rabbit, 1:2,000, kindly provided by J.M. Fritschy),
GABAAa2 receptor subunit (polyclonal guinea-pig, 1:2,000, kindly provided
by J.M. Fritschy), and GABAAa3 receptor subunit (polyclonal guinea-pig,
1:3,000, kindly provided by J.M. Fritschy). Secondary antibodies utilized
were either anti-isotypic Alexa Fluor conjugates (1:1,000, Invitrogen, Carlsbad,
CA, USA) or DyLight conjugates (1:1,000, Jackson ImmunoResearch, West
Grove, PA, USA).
Imaging and Analysis
Image stacks were acquired on an Olympus FV1000 laser scanning confocal
microscope. Fixed tissue was imaged using a 1.35 NA 603 oil immersion
objective at a voxel size of 0.069, 0.069, 0.3 mm or 0.051, 0.051, 0.3 mm
(x, y, z) for images used in quantification. To visualize RBC-amacrine cell
contacts at different developmental time points, we crossed the GAD67-
GFP and grm6-tdtomato mouse lines and imaged the retinas using a
custom-built two-photon microscope and an Olympus 603 water objective.
Each optical plane was averaged three to four times. Raw image stacks
were processed using MetaMorph (Molecular Devices, Sunnyvale, CA, USA)
and Amira (Visualization Sciences Group, Burlington, MA, USA). For volume
estimation, the PKC signal of RBC boutons was masked in three dimensions
using the ‘‘label field’’ function of Amira. Subsequently, this PKC mask was
multiplied with the GAD or GABA receptor channel to isolate signal specifically
within the RBC boutons. Next, a constant threshold for image stacks from the
same retina (including WT-KO region comparison across the retina), was
applied to detect the volume occupied by the signal using the ‘‘label voxel’’
function of Amira. The percent of signal volume as compared to PKC mask
volume was estimated using the ‘‘tissue statistics’’ function of Amira.
The specificity of GABA receptor antibodies utilized in this study was tested
by performing colocalization analysis and assessing the extent of random
associations (Soto et al., 2011). In vertical retinal sections, we found 87% of
GABAAa3 receptor clusters apposed to the presynaptic marker, VIAAT.
Electron Microscopy
Retinas were fixed by eyecup immersion in 2% paraformaldehye/2% glutaral-
dehyde in 0.1M sodium cacodylate buffer (pH 7.4) for 3 hr. The tissue was then
washed in buffer, fixed further in 1% osmium tetroxide in cacodylate buffer
for 1 hour prior to en bloc staining with 1% uranyl acetate. The tissue was
then dehydrated in graded ethanol series, embedded in araldite resin,
sectioned, and stained with 5% lead citrate.
Western Blot
Retinas from GAD1KO and littermate control mice (two retinas pooled per an-
imal) were prepared on ice in homogenizing buffer (50mMTRIS, 150mMNaCl,
1% Triton X-100, 1% Na-deoxycholate, and 0.1% SDS) containing protease
inhibitor cocktail. Samples (30 mg/ml per lane) were run by SDS-PAGE (10%
resolving gel), blotted onto nitrocellulose membranes, incubated with anti-
bodies, and visualized with enhanced chemiluminescence. Primary antibodies
utilized were directed against GAD67 (mouse monoclonal, 1:2,000, Chemi-
con), GABAAa1 receptor subunit (polyclonal rabbit, 1:2,000, kindly provided
by J.M. Fritschy), or actin (mouse monoclonal, 1:3,000, Chemicon). For prep-
aration of samples to compare GABAAa1 levels from retinal homogenates, the
dorsal-ventral wedge of the retina was not included for both GAD1KO and
littermate control samples.
Preparation of Mouse Retinal Slices for Whole-Cell Recording
The preparation of retinal slices has been described in detail by Eggers and
Lukasiewicz (2006a). In brief, the eyecup was incubated for 20 min in mACSF
containing 0.5 mg/ml hyaluronidase (Sigma-Aldrich) to remove any remaining
vitreous. The retinas were then put onto filter paper (HABP013, Millipore) with
the photoreceptor layer facing up. Vertical retinal slices of 200 mm thickness
were cut using a standard technique (Werblin, 1978) and subsequently stored
in carbogenated mACSF at room temperature.
Whole-Cell Recordings and Data Analysis
Whole-cell recordings were made from RBCs (in GAD1KO and grm6-TeNT)
and A17s (inGAD1KO andGABACKO) in retinal slices as previously described
(Eggers and Lukasiewicz, 2006a; Schubert et al., 2008). The resistance of the
Neuron
Presynaptic Inhibition on Axonal Terminalselectrodes with standard solutions usually ranged between 6 and 8MU. Liquid
junction potentials of 15 mV were corrected before measurements with the
pipette offset function. Series resistance (mean: 67.6 ± 3.7 MU, n = 18) and
capacitance of pipettes as well as cell capacitance were not compensated.
Seal resistances >1 GUwere routinely obtained. To record GABA-evoked cur-
rents and spontaneous inhibitory postsynaptic currents (sIPSCs) in RBCs, we
voltage-clamped these cells at 0 mV, the reversal potential for cation-
mediated currents through ionotropic glutamate receptors. For all RBC
recordings, glycinergic input and network activity were blocked by strychnine
(0.5 mM) and TTX (1 mM), respectively. For A17 amacrine cells, excitatory
postsynaptic currents mediated by ionotropic glutamate receptors (sEPSCs)
were recorded at a holding potential of 60 mV, the reversal potential for
chloride-mediated currents set by the internal solution (Schubert et al.,
2008). Action potentials in A17s were blocked by including QX-314 (2 mM) in
the intracellular solution. For recording sEPSCs from P11–P13 A17s in the
presence of GABA receptor blockers, TPMPA (50 mM) and SR95531 (5 mM)
were included in the extracellular mACSF solution. The holding current
was monitored during the experiment, and recordings with shifting holding
currents were aborted. All experiments were carried out at room temperature
(20C–22C) and under room light conditions.
Data acquisition was performed using an Axopatch 200B amplifier with an
acquisition frequency of 10 kHz using the Clampex software (Axon Instru-
ments, Foster City, CA, USA). Signals were 2 kHz Bessel filtered. Data were
further processed using a routine written in Igor Pro 6 (Wavemetrics, Portland,
OR, USA) and visualized with Origin software (Microcal, Northampton, MA,
USA). To quantify parameters of spontaneous synaptic events, the mean
frequency ± SEM and the mean peak amplitude ± SEM of the events were
determined. To quantify evoked currents, peak amplitude and total charge
transfer (as complete area under the curve), both relative to the preapplication
baseline current, were determined and averaged across cells. In addition,
we characterized the kinetics of the evoked current by determining the time
points from the exponential fits at which the traces reached 20% and 80%
of the peak amplitude and calculated the differences, t20-80 rise and t80-20
decay.
Solution and Drugs
The extracellular solution used for recording (mACSF) contained (in mM) 122.5
NaCl, 5 KCl, 1 MgCl2, 1.25 NaH2PO4, 26 NaHCO3, 2 CaCl2, and 20 glucose,
adjusted to pH 7.4 with 95% O2 and 5% CO2. The intracellular solution con-
tained (in mM) 120 cesium gluconate, 1 CaCl2, 1 MgCl2, 10 Na-HEPES, 11
EGTA, and 10 TEA-Cl and was adjusted to pH 7.2 with CsOH. Under our
experimental conditions, the calculated chloride equilibrium potential was
59.3 mV. To block GABAC receptors and GABAA receptors, (1,2,5,6-tetrahy-
dropyridine-4yl) methyphospinic acid (TPMPA, 50 mM) and SR95531 (5 mM)
were used, respectively. All drugs were purchased from Sigma-Aldrich.
Solutions in the recording chamber were exchanged using a gravity-driven
superfusion system previously described (Lukasiewicz and Roeder, 1995).
GABA receptor and glutamate receptor agonists, GABA (200 mM) and AMPA
(100 mM), were dissolved in mACSF with 0.005% sulforhodamine B and
applied with a puff pipette (5–7 MU) using a Picospritzer system. Puffing direc-
tions, as well as the duration of the 300 ms puff, were chosen such that the
axonal terminal of the patched RBC was completely covered by the puff,
visualized by including sulforhodamine B in the puffer pipette.
Statistics
For comparisons across data sets, the Wilcoxon rank-sum test was used in all
cases. *p < 0.05; **p < 0.01; ***p < 0.001.
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